Crypto & Consumers, $9B AI Tool, Weighing the Trades 10/3/23
About this episode
Two big legal cases concerning the fate of FTX founder Sam Bankman-Fried and the CFPB. We’ve got the latest developments on each. Plus, is Microsoft’s new $9B AI tool worth the hype? And the weight-loss drug boom is having major ripple effects on stocks. We’ll look at one buy and one bail as a result of the craze.
Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.
Get every episode summarized
Each time The Exchange publishes, we email you a written briefing from the transcript — the topics, who appeared, and any specific claims, with the ad reads skipped.
Email me new episodesFree for 3 shows. No card needed.
No transcript yet
This episode has not been transcribed. Request it and it moves to the front of the queue.
More episodes
More from The Exchange
Crude’s “Crash Diet,” Tariff Tiff, and Hold off on a Hike? 9/8/26
The Exchange
Jobs Jolt, Hugging Face’s First Investor, and Where the Pricing Power Is 9/4/26
The Exchange
Nvidia Buys Hugging Face, AI Outages, and Data Center Dissent 9/3/26
The Exchange
The Great Data Center Debate, Apple’s New Era, and Not Swooning in September 9/2...
The Exchange